title: Regulation of Wnt/beta-catenin pathway by cPLA2alpha and PPARdelta.
abstract: Cytosolic phospholipase A(2)alpha (cPLA(2)alpha) is a rate-limiting key enzyme that releases arachidonic acid (AA) from membrane phospholipid for the production of biologically active lipid mediators including prostaglandins, leukotrienes and platelet-activating factor. cPLA(2)alpha is translocated to nuclear envelope in response to intracellular calcium increase and the enzyme is also present inside the cell nucleus; however, the biological function of cPLA(2)alpha in the nucleus remains unknown. Here we show a novel role of cPLA(2)alpha for activation of peroxisome proliferator-activated receptor-delta (PPARdelta) and beta-catenin in the nuclei. Overexpression of cPLA(2)alpha in human cholangiocarcinoma cells induced the binding of PPARdelta to beta-catenin and increased their association with the TCF/LEF response element. These effects are inhibited by the cPLA(2)alpha siRNA and inhibitors as well as by siRNA knockdown of PPARdelta. Overexpression of PPARdelta or treatment with the selective PPARdelta ligand, GW501516, also increased beta-catenin binding to TCF/LEF response element and increased its reporter activity. Addition of AA and GW501516 to nuclear extracts induced a comparable degree of beta-catenin binding to TCF/LEF response element. Furthermore, cPLA(2)alpha protein is present in the PPARdelta and beta-catenin binding complex. Thus the close proximity between cPLA(2)alpha and PPARdelta provides a unique advantage for their efficient functional coupling in the nucleus, where AA produced by cPLA(2)alpha becomes immediately available for PPARdelta binding and subsequent beta-catenin activation. These results depict a novel interaction linking cPLA(2)alpha, PPARdelta and Wnt/beta-catenin signaling pathways and provide insight for further understanding the roles of these key molecules in human cells and diseases.
authors.affiliation: Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA. changhan@pitt.edu
authors.forename: Chang
authors.initials: C
authors.lastname: Han
authors.forename: Kyu
authors.initials: K
authors.lastname: Lim
authors.forename: Lihong
authors.initials: L
authors.lastname: Xu
authors.forename: Guiying
authors.initials: G
authors.lastname: Li
authors.forename: Tong
authors.initials: T
authors.lastname: Wu
mesh_terms: D016824:Antigens, Human Platelet / Q000378:metabolism / Q000502:physiology*; D016718:Arachidonic Acid / Q000494:pharmacology; D002467:Cell Nucleus; D018281:Cholangiocarcinoma / Q000473:pathology; D006801:Humans; D047494:PPAR delta / Q000378:metabolism / Q000502:physiology*; D011485:Protein Binding; D020218:Response Elements; D051820:TCF Transcription Factors / Q000235:genetics*; D014407:Tumor Cells, Cultured; D051155:Wnt1 Protein / Q000378:metabolism*; D051176:beta Catenin / Q000378:metabolism*
chemical_list: D016824:Antigens, Human Platelet; D047494:PPAR delta; D051820:TCF Transcription Factors; D051155:Wnt1 Protein; D051176:beta Catenin; C083451:human platelet antigen 1b; D016718:Arachidonic Acid